Mind-NRG's Series A Round

Mind-NRG raised a round of funding on October 21, 2010. Investors include Index Ventures.

Mind-NRG is devoted to the development of NRG-101 in psychiatric and neurologic diseases. NRG-101 is a neurotrophic factor with disease modifying potential that naturally crosses the blood-brain barr…

Articles about Mind-NRG's Series A Round: